Efficacy of Helicobacter pylori eradication therapy concomitantly with probiotics in relation to changes in the intestinal microbiota

Trial Profile

Efficacy of Helicobacter pylori eradication therapy concomitantly with probiotics in relation to changes in the intestinal microbiota

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Esomeprazole (Primary) ; Amoxicillin; Clarithromycin; Probiotics
  • Indications Duodenal ulcer; Helicobacter pylori infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top